Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kulke, MH; Niedzwiecki, D; Foster, NR; Fruth, B; Kunz, PL; Kennecke, HF; Wolin, EM; Venook, AP

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15_suppl

Start / End Page

  • 4005 - 4005

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2015.33.15_suppl.4005